Menora Mivtachim Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Menora Mivtachim Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$396K	Hold	2,500	–	–	﹤0.01%	162
2026 Q1	$319K	Sell	2,500 -2,500	-50%	-$312K	﹤0.01%	148
2025 Q4	$610K	Hold	5,000	–	–	﹤0.01%	118
2025 Q3	$501K	Hold	5,000	–	–	﹤0.01%	118
2025 Q2	$415K	Hold	5,000	–	–	﹤0.01%	117
2025 Q1	$406K	Hold	5,000	–	–	﹤0.01%	112
2024 Q4	$450K	Sell	5,000 -500	-9%	-$48.4K	﹤0.01%	88
2024 Q3	$543K	Buy	+5,500	New	+$540K	﹤0.01%	82
2024 Q1	–	Sell	-4,000	Closed	-$357K	–	99
2023 Q4	$357K	Hold	4,000	–	–	﹤0.01%	90
2023 Q3	$292K	Buy	+4,000	New	+$320K	﹤0.01%	90

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Menora Mivtachim Holdings's XBI Position: Q2 2026 in Review

Menora Mivtachim Holdings held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,500 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #162.

Menora Mivtachim Holdings first reported a position in XBI in Q3 2023 and has held it in 10 quarters since. The position peaked at $610K in Q4 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Menora Mivtachim Holdings held 2,500 shares of State Street SPDR S&P Biotech ETF worth $396K as of Q2 2026.
Menora Mivtachim Holdings left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Menora Mivtachim Holdings's portfolio in Q2 2026, its #162 holding.
Menora Mivtachim Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 10 quarters since.
Menora Mivtachim Holdings's State Street SPDR S&P Biotech ETF position peaked at $610K in Q4 2025.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.